• Immunohistochemistry analysis of paraffin-embedded human normal prostate tissues (left) and prostate adenocarcinoma tissues (right) , showing cytoplasmic localization with DAB staining using AMACR monoclonal antibody.
  • Confocal immunofluorescence analysis of LNCaP cells using AMACR monoclonal antibody (green). Red: Actin filaments have been labeled with DY-554 phalloidin. Blue: DRAQ5 fluorescent DNA dye.
  • Western blot analysis using AMACR monoclonal antibody against Jurkat (1) and LNCaP (2) cell lysate.

Anti-AMACR antibody [2A10F3] (STJ97825)

SKU:
STJ97825

Current Stock:
Host: Mouse
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Alpha-methylacyl-CoA racemase is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Monoclonal
Clone ID: 2A10F3
Conjugation: Unconjugated
Isotype: IgG2b
Formulation: Liquid in PBS containing 0.03% Sodium Azide, 0.5% BSA, 50% Glycerol.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
IHC 1:200-1:1000
IF 1:200-1:1000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: AMACR
Gene ID: 23600
Uniprot ID: AMACR_HUMAN
Specificity: AMACR Monoclonal Antibody detects endogenous levels of AMACR protein.
Immunogen: Purified recombinant fragment of human AMACR expressed in E. Coli.
Protein Name Alpha-Methylacyl-Coa Racemase
2-Methylacyl-Coa Racemase
Database Links Reactome: R-HSA-193368
Reactome: R-HSA-193775
Reactome: R-HSA-389887
Reactome: R-HSA-9033241
Cellular Localisation Peroxisome
Mitochondrion
Alternative Antibody Names Anti-Alpha-Methylacyl-Coa Racemase antibody
Anti-2-Methylacyl-Coa Racemase antibody
Anti-AMACR antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance